Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545857 · ClinicalTrials.gov registry record · Phase 1
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
A Phase 1 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00545857 is a Phase 1 study that has completed, run by Stony Brook University. The registered enrollment target is 15 participants.
The verdict
NCT00545857, a Phase 1 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
A study to examine the effect of pioglitazone on the course of new onset type 1 diabetes mellitus.
Interventions
- DRUG Placebo control
- DRUG pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-06 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545857
The ClinicalTrials.gov registry entry for NCT00545857 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT00545857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545857 about?
NCT00545857 is a clinical study titled "Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus". A study to examine the effect of pioglitazone on the course of new onset type 1 diabetes mellitus.
What is the current status of trial NCT00545857?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2002-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00545857?
The interventions under investigation include: Placebo control (DRUG), pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00545857?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.